RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 ( RIP1 ) with an IC 50 of 13 nM. RIPA-56 can be used for the treatment of systemic inflammatory response syndrome.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > RIP kinase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.